🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users administering substances of unknown origin.

Several professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Response and Material Elimination

According to TikTok, the service has taken down problematic content and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Activities

Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of weight loss, positive reviews and detailed instructions for preparing or administering at residence.

Within moments of entering one group, a seller posted contact information, where the majority of purchases take place. The seller sent an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these communities, posts display dark colored parcels with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially serious health risks”.